PROSPECTS OF NEPHROPROTECTION AGAINST TYPE 2 DIABETES USING THE DPP-4 INHIBITOR VILDAGLIPTIN

PROSPECTS OF NEPHROPROTECTION AGAINST TYPE 2 DIABETES USING THE DPP-4 INHIBITOR VILDAGLIPTIN

Diabetic nephropathy (DN) is a serious complication of diabetes mellitus (DM), which increases morbidity and mortality. Accumulated evidence, mostly experimental ones that DPP-4 inhibitors have non-glycemic tissue effects including renal protection. Clinical data confirming these effects are insuffi...

Full description

Bibliographic Details
Main Authors: V. K. Bayrasheva, A. Y. Babenko, A. A. Bayramov, S. G. Chefu, I. S. Shatalov, I. Y. Pchelin, A. N. Arefieva, E. N. Grineva
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-12-01
Series:Медицинский совет
Subjects:
vildagliptin
nephroprotection
diabetic nephropathy
urinary excretion of type iv collagen
egfr by cystatin s
Online Access:https://www.med-sovet.pro/jour/article/view/1742

Internet

https://www.med-sovet.pro/jour/article/view/1742

Similar Items